Abstract: The thiolic salts of erythromycin and of the propionic ester of erythromycin with thenoyl alpha-mercaptopropionylglycine find therapeutical use in the cases in which erythromycin or its propionic ester are used and are generally endowed with very low toxicity and high hematic levels.
Type:
Grant
Filed:
February 2, 1982
Date of Patent:
October 9, 1984
Assignee:
Sigma Tau Indistrie Farmaceutiche Riunites, p.A